良性前列腺增生

  • 网络Benign Prostatic Hyperplasia;BPh;Benign prostatic hypertrophy
良性前列腺增生良性前列腺增生
  1. bcl-2基因在良性前列腺增生中的作用

    Action of protooncogene bcl 2 in the development of BPH

  2. 目的:寻找治疗小体积良性前列腺增生(BPH)患者的最佳治疗方式。

    Purpose : To evaluate the therapy of patients with small size BPH .

  3. 良性前列腺增生CT灌注成像研究

    CT perfusion weighted imaging in the benign prostatic hyperplasia

  4. 良性前列腺增生的CT表现

    CT Findings of Benign Prostatic Hyperplasia

  5. 良性前列腺增生患者血清PSA与年龄变化的关系

    Variation of serum PSA with age in benign prostatic hyperplasia patients

  6. 目的分析良性前列腺增生(BPH)患者出现肾积水的尿动力学机制。

    Objective To clarify the urodynamic mechanism of hydronephrosis due to BPH .

  7. 其中良性前列腺增生症(BPH)475例;

    Among them , 475 patients were benign prostatic hyperplasia ( BPH );

  8. 良性前列腺增生(BPH)是老年男性的常见病和多发病。

    Benign prostatic hyperplasia ( BPH ) was a frequent and multi-occurred disease .

  9. 目的:评价在良性前列腺增生(BPH)开放手术的同时行经腹膜前腹股沟疝修补术的疗效。

    Objective : To evaluate the effect of simultaneous open prostatectomy and preperitoneal inguinal herniorrhaphy .

  10. 目的:观察真武汤对肾阳亏虚型良性前列腺增生症(BPH)的疗效。

    Purpose : To observe the therapeutic effects of Zhenwu Decoction on benign hyperplasia prostate .

  11. 症状性良性前列腺增生(BPH)是男性老年患者常见病。

    Benign Prostatic Hyperplasia ( BPH ) is the normal disease of old male patients .

  12. 目的:探讨良性前列腺增生症(BPH)的有效治疗方法。

    Objective : To study effective methods to treat benign prostatic hyperplasia ( BPH ) .

  13. 良性前列腺增生的MRS与血清PSA、PSAD相关性初步研究

    Study of correlation between MRS and serum PSA / PSAD in benign prostatic hyperplasia

  14. KTP激光汽化术治疗良性前列腺增生

    Potassium titanyl phosphate laser vaporization prostatectomy for the treatment of benign prostatic hyperplasia

  15. 方法:对157例有症状的良性前列腺增生症(BPH)患者行保留尿道前列腺切除术。

    Methods : Prostatectomy with reserving the prostatic urethra was performed for 157 cases of BPH .

  16. 目的评价接触式激光前列腺下半部切除术治疗大体积良性前列腺增生症(BPH)的疗效。

    Objective To evaluate the safety and efficacy of the transurethral contact laser lower half prostatectomy .

  17. 方法对44例良性前列腺增生(BPH)患者进行自由尿流率和压力流率测定。

    Methods Forty-four men with lower urinary tract symptoms underwent free uroflometry and pressure-flow study respectively .

  18. 结果:前列腺癌组织中HIF-1α和VEGF的表达均明显高于良性前列腺增生症(BPH)组织中;

    Results : HIF-1 α and VEGF levels in prostate cancer were much higher than those in BPH ;

  19. 良性前列腺增生患者中组织学前列腺炎对PSA及前列腺体积的影响

    Effects of Histological Prostatitis on Serum Prostate Special Antigen and Prostate Volum in Patients with Benign Prostatic Hyperplasia

  20. 良性前列腺增生症(Benignprostatichyperplasia,BPH)是一种以排尿困难为主要临床特征的常见的男性老年性疾病。

    Benign Prostatic Hyperplasia ( BPH ) is a kind of frequent male old-age disease which clinical feature is urine difficulty .

  21. 方法对210例经临床和病理确诊为良性前列腺增生(BPH)的患者资料作回顾性研究。

    Methods The data of 210 consecutive patients with clinically and pathologically proven BPH were retrospectively analyzed .

  22. 良性前列腺增生(BPH)是泌尿外科的常见疾病。

    ObjectsBenign prostatic hyperplasia ( BPH ) is a common clinical disease of the department of urology .

  23. PVR和PSAD:前列腺癌与良性前列腺增生的鉴别

    The clinical value of PVR and PSAD in distinguishing PCa and BPH

  24. IGF-1和其受体IGF-1R在前列腺癌和良性前列腺增生组织中的表达

    Expression of IGF-1 and IGF-1R in prostate cancer and benign prostatic hyperplasia

  25. 通道法TURP与前列腺包膜切开术联合治疗良性前列腺增生症高危患者

    Treatment of High Risk BPH Patients by TUIP Combined with Channel TURP

  26. 三组间两两进行比较,前列腺癌组与良性前列腺增生组比较,P0.01,差异有统计学意义。

    Three groups were compared pairwise . The difference of prostate cancer and benign prostatic hyperplasia group was statistically significant ( P0.01 ) .

  27. 目的探讨经尿道射频消融治疗良性前列腺增生(BPH)的疗效及机理。

    Objective To study the efficacy and mechanism of transurethral needle ablation of prostate in the treatment of BPH .

  28. 目的分析α受体阻滞剂对良性前列腺增生(BPH)患者症状的影响。

    Objective To analysis the impact of α blocker therapy on symptoms of benign prostatic hyperplasia ( BPH ) .

  29. 目的探讨老年性高血压与良性前列腺增生(BPH)的关系。

    Objective To investigate the relationship between hypertension and benign prostatic hyperplasia ( BPH ) in rural elder people .

  30. 共检出前列腺癌11例、良性前列腺增生(BPH)9例、前列腺结核1例。

    Eleven cases were pathological prostate cancer , 9 cases benign prostate hyperplasia , and 1 case prostate tuberculosis .